Orchid Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 10% in the latest quarter indicates strong demand and market positioning.
Profitability improved significantly, reaching ₹29.43 crore in the latest quarter, up from ₹19.80 crore.
Operating profit margin has consistently increased, suggesting better cost management and operational efficiency.

NEGATIVES

Net profit declined to ₹27.24 crore in the latest quarter, down from ₹29.35 crore, signaling potential challenges ahead.
Recent quarter saw a decrease in revenues compared to the previous quarter, raising concerns about sustainability.
Higher expenses in material costs may impact margins if not controlled effectively.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	182.92	198.75	220.59	217.10	244.41	222.70	217.34	172.93
Expenses	174.03	187.09	198.01	200.08	223.86	204.31	203.38	170.67
Operating Profit	8.89	11.67	22.58	17.02	20.55	18.38	13.96	2.26
Other Income	1.89	8.36	7.62	13.36	7.57	7.52	8.49	11.45
Interest	5.54	3.80	3.54	3.47	3.50	3.33	3.80	3.26
Depreciation	7.71	7.84	9.27	8.42	8.44	8.63	8.61	8.65
Profit Before Tax	9.40	19.80	29.43	29.84	29.20	27.24	20.78	14.91
Tax	0	0	0	-3.12	-0.15	0	0	0
Net Profit	9.40	19.80	29.43	32.96	29.35	27.24	20.77	14.91
Eps in Rs	1.85	4.30	6.18	6.81	5.79	5.37	4.10	2.94